Search results
Results from the WOW.Com Content Network
In the European Union, the European Medicines Agency has jurisdiction and the relevant documents are called the "summary of product characteristics" (SPC or SmPC) and the document for end-users is called the "patient information leaflet" or "package leaflet". The SPC is not intended to give general advice about treatment of a condition but does ...
The Electronic Medicines Compendium is a provider of information on medicines, produced by Datapharm. It lists summaries of product characteristics and patient information leaflets . [ 1 ] [ 2 ]
Patient.info is an online resource providing information on health, lifestyle, disease and other medical related topics. The website's aim is to provide members of the public with up-to-date information on health related topics in the form of comprehensive leaflets (which can be read online or printed), blogs, wellbeing advice and videos.
Patient portals are healthcare-related online applications that allow patients to interact and communicate with their healthcare providers, such as physicians and hospitals. Typically, portal services are available on the Internet at all hours of the day and night.
MedlinePlus is an online information service produced by the United States National Library of Medicine.The service provides curated consumer health information in English and Spanish with select content in additional languages.
When purchasing a drug under the PBS, the consumer pays no more than the patient co-payment contribution, which, as of January 1, 2022, is A$42.50 for general patients. Those covered by government entitlements (low-income earners, welfare recipients, Health Care Card holders, etc.) and or under the Repatriation Pharmaceutical Benefits Scheme ...
In the US the document is called "prescribing information" or the "package insert" (PI) and layperson's document is called the "patient package insert" (PPI). [15] In Europe the technical document is called the "summary of product characteristics" and the document for end-users is called the "package leaflet". [19]
In the case of estradiol/levonorgestrel, detailed ePRO data on bleeding/spotting from a one-year clinical trial are presented in the patient information leaflet. [17] As well as clinical trial use, ePRO methods may be used to support patients in regular care.